2. Zogenix (ZGNX - Get Report), a specialty pharmaceutical company, has two proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. Its two products are SUMAVEL DosePro, its first commercial product, and its lead product candidate ZX002.
10 Earnings to Watch Monday
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.